Good sources include olive oil, avocado, nuts, seeds, and fatty fish
However, analysts at Leerink were critical of the latter, saying that there were no significant increases in free fatty acids whereas free fatty acids decreased by 7.5 percent with pooled groups of tirzepatide in the Phase III SURMOUNT-1 trial. The analysts were referring to trial data for Eli Lillys Zepbound, which demonstrated a mean weight loss of 21.1 percent over 36 weeks in its trials involving nondiabetic patients with obesity or overweight, making MariTides results roughly on par with Zepbound, despite the difficulty of cross-trial comparisons
In fact, it is generally restricted to patients who meet the following criteria: Those with a body mass index (BMI) of 30 or higher Those with a BMI of 27 or higher who also have weight-related health conditions (diabetes, high blood pressure, etc.) What Results Can I Expect from GLP-1s Weight Loss
They may recommend switching to oral tirzepatide, adjusting your injection depth or angle, or exploring alternative peptide therapies tailored to your genetic and clinical profile
